Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alpha-2b in Chronic Hepatitis B With Normal ALT and Low Viremia
NCT05203055Phase 2Unknown
- Sponsor
- 900th Hospital of Joint Logistics Support Force of PLA
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of peginterferon alfa-2b in Chronic Hepatitis B (CHB), sponsored by 900th Hospital of Joint Logistics Support Force of PLA. Status: unknown.
02
Drugs
peginterferon alfa-2b
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05203055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05203055.